In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Evalve: Leading the Valve Revolution

Executive Summary

Full-scale commercialization of percutaneous heart valve technology is still years away, but Evalve's new approach to mitral repair is closest to the clinic.
Advertisement

Related Content

Proving Device Incubation Works: An Interview with The Foundry
Abbott Moves into Heart Valves with Evalve Deal
Market & Industry Briefs
Medical Device and In Vitro Diagnostics Deal Statistics Quarterly, Q4 2007
ValveXchange Inc.
Stent Recap: Turmoil in 2007--What's Ahead for Interventional Cardiology?
New Approaches to Heart Valve Repair and Replacement
In Minimally-Invasive Heart Valves, Edwards Cuts a Wide Swath
Growing Companies--Part II
Growing Companies--Part 1

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002813

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel